Insulin Therapy for A1C of 6.9%

Assessment and Clinical Decision-Making

The American Diabetes Association recommends an A1C target of <7% for many nonpregnant adults, and an A1C of 6.9% is already below this target goal 1, 3
An A1C level of 6.9% indicates good glycemic control and does not require insulin initiation based on A1C alone, according to the American Diabetes Association 2
An A1C of 6.9% corresponds to an estimated average glucose of approximately 151 mg/dL, which is within an acceptable range for most patients 3
Insulin therapy is not recommended for a patient with an HbA1C level of 6.9% unless there are specific clinical indicators such as catabolic features or severe hyperglycemia, as stated by the American Diabetes Association 1, 2

For patients with A1C of 6.9%, the focus should be on maintaining current therapy rather than intensifying to insulin, as recommended by the American Diabetes Association 2
The American Diabetes Association suggests that some patients may even qualify for deintensification of therapy if they are already on multiple medications, as A1C <7% is the target for most patients 7
If A1C is 6.9% but blood glucose readings show significant variability or frequent hyperglycemia, consider continuous glucose monitoring to better assess glycemic patterns, according to the American Diabetes Association 1, 3

If A1C is trending upward despite being at 6.9%, consider optimizing current oral medications before adding insulin, as recommended by the American Diabetes Association 4
For patients with A1C near target but with postprandial hyperglycemia, consider adding medications that target postprandial glucose rather than insulin, according to the American Diabetes Association 5

Avoid overtreatment based solely on A1C, as this increases the risk of hypoglycemia without clear clinical benefit, as stated by the American Diabetes Association 7
Starting insulin at A1C of 6.9% may lead to unnecessary treatment burden, weight gain, and hypoglycemia risk, according to the American Diabetes Association 8, 9
In specific populations, such as the elderly or those with limited life expectancy, an A1C of 6.9% may actually be lower than their individualized target, as recommended by the American Diabetes Association 8, 2

Continue regular monitoring of A1C every 3-6 months, as recommended by the American Diabetes Association 1
Consider using time in range metrics if the patient is using continuous glucose monitoring, with a goal of >70% time in range (70-180 mg/dL), according to the American Diabetes Association 1, 3
Monitor for hypoglycemia, especially if the patient is on sulfonylureas or other medications that increase hypoglycemia risk, as stated by the American Diabetes Association 2